publication venue for
- Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand. 42:337-344. 2017
- Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient. 42:111-114. 2017
- Simvastatin monotherapy as a potential option for statin-associated muscle symptoms: a case report. 41:568-571. 2016
- Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population. 40:186-191. 2015
- The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-Control Study. 40:110-115. 2015
- Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study. 39:511-515. 2014
- The cardiovascular effects of glucagon-like peptide-1 receptor agonists: a trial sequential analysis of randomized controlled trials. 39:7-13. 2014
- CYP2E1,GSTM1andGSTT1genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study. 37:588-593. 2012
- Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary care. 34:387-395. 2009
- The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1receptor antagonism ? or inverse agonism ? as potential obesity treatment and other therapeutic use. 32:209-231. 2007